Peptides for Thyroid Support: Can BPC-157 Help Thyroid Function?

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

While traditional thyroid treatments focus on hormone replacement, emerging research is exploring the potential of peptides to support and modulate thyroid function. Among these, BPC-157 (Body Protection Compound-157) stands out due to its potent regenerative and anti-inflammatory properties. Although direct human studies on BPC-157 for primary thyroid disorders are limited, its systemic effects on gut health, inflammation, and tissue repair suggest indirect benefits for overall endocrine balanc

While traditional thyroid treatments focus on hormone replacement, emerging research is exploring the potential of peptides to support and modulate thyroid function. Among these, BPC-157 (Body Protection Compound-157) stands out due to its potent regenerative and anti-inflammatory properties. Although direct human studies on BPC-157 for primary thyroid disorders are limited, its systemic effects on gut health, inflammation, and tissue repair suggest indirect benefits for overall endocrine balance, including thyroid support.

Understanding BPC-157

BPC-157 is a stable gastric pentadecapeptide, a short chain of 15 amino acids, naturally found in human gastric juice. It has garnered significant attention in regenerative medicine due to its remarkable healing capabilities across various tissues, including tendons, ligaments, muscles, bones, and the gastrointestinal tract. Its mechanisms of action are diverse and include:

• Angiogenesis: Promoting the formation of new blood vessels, crucial for tissue repair and nutrient delivery.
• Growth Factor Modulation: Interacting with growth factors like VEGF (Vascular Endothelial Growth Factor) and EGF (Epidermal Growth Factor) to accelerate healing.
• Anti-inflammatory Effects: Reducing inflammation by modulating cytokine production and stabilizing mast cells.
• Cytoprotection: Protecting cells from damage and promoting cell survival.
• Gut Healing: Rapidly healing ulcers, fistulas, and improving intestinal barrier function (leaky gut) [1].

Indirect Thyroid Support Mechanisms of BPC-157

While BPC-157 does not directly stimulate thyroid hormone production or act as a thyroid hormone itself, its broad systemic effects can indirectly support optimal thyroid function, particularly in the context of underlying conditions that often co-exist with thyroid dysfunction:

• Gut Health and Autoimmunity: A significant portion of the immune system resides in the gut, and gut dysbiosis or "leaky gut" is strongly implicated in the development and exacerbation of autoimmune thyroid conditions like Hashimoto's thyroiditis. BPC-157's profound gut-healing properties can restore intestinal barrier integrity, reduce systemic inflammation, and potentially modulate the autoimmune response, thereby creating a more favorable environment for thyroid health [2].
• Reducing Systemic Inflammation: Chronic inflammation is a known suppressor of thyroid function, impairing T4 to T3 conversion and increasing reverse T3 (rT3) production. By exerting potent anti-inflammatory effects, BPC-157 can help reduce the inflammatory burden on the thyroid gland and improve peripheral thyroid hormone metabolism.
• Adrenal Support and Stress Response: The HPA (hypothalamic-pituitary-adrenal) axis and the HPT (hypothalamic-pituitary-thyroid) axis are intimately linked. Chronic stress and adrenal dysfunction can negatively impact thyroid function. BPC-157 has been shown to have protective effects against stress-induced damage and may help normalize the stress response, indirectly benefiting thyroid health [3].
• Tissue Repair and Regeneration: Optimal thyroid function relies on healthy glandular tissue. While not a direct thyroid regenerator, BPC-157's general tissue-healing properties could theoretically support the overall health of the thyroid gland, especially if there has been damage from inflammation or autoimmune attack.

Dosing and Administration

BPC-157 is typically administered via subcutaneous injection, with common dosing ranging from 200-500 mcg daily, often split into two doses, for a duration of 4-8 weeks. Oral administration in enteric-coated capsules is also available, though bioavailability may vary. It is crucial to source BPC-157 from reputable suppliers and to use it under the guidance of a healthcare practitioner, especially when considering it for complex conditions like thyroid dysfunction.

Clinical Perspective and Future Research

From a clinical perspective, BPC-157 is not a first-line treatment for hypothyroidism or hyperthyroidism. However, for patients with autoimmune thyroiditis (Hashimoto's) who also present with significant gut issues, chronic inflammation, or adrenal dysregulation, BPC-157 could be a valuable adjunctive therapy. By addressing these underlying systemic imbalances, it may help create a more conducive environment for thyroid hormone optimization and overall well-being.

Further human clinical trials specifically investigating BPC-157's direct and indirect effects on thyroid function are needed to fully elucidate its therapeutic potential in this area. Until then, its use for thyroid support remains largely based on its known systemic benefits and anecdotal clinical experience.

References

[1] Sikiric, P. C., et al. (2010). A new gastric pentadecapeptide BPC 157 as an anti-ulcer anti-inflammatory agent. Current Pharmaceutical Design, 16(10), 1224-1234. https://pubmed.ncbi.nlm.nih.gov/20210712/

[2] Sikiric, P. C., et al. (2019). Stable Gastric Pentadecapeptide BPC 157 in trials for inflammatory bowel disease (IBD) and ulcerative colitis (UC): a review. Current Pharmaceutical Design, 25(23), 2509-2517. https://doi.org/10.2174/1381612825666190719100804

[3] Sikiric, P. C., et al. (2013). Stable gastric pentadecapeptide BPC 157 and its role in stress-response. Current Pharmaceutical Design, 19(4), 764-771. https://pubmed.ncbi.nlm.nih.gov/23092288/